Next Orthosurgical

Next Orthosurgical specializes in spinal fixation devices. Their portfolio includes non-bioabsorbable bone screws, internal spinal fixation rods, polymeric spinal interbody fusion cages, vertebral body prostheses, reusable surgical implant templates, and trial implants for spinal procedures. These devices are designed to support spinal stabilization and fusion during surgical interventions.

Next Orthosurgical is based in the United States. As a U.S.-based manufacturer, its devices are subject to FDA regulations, including classification under FDA’s risk-based system (Class I or Class II). This ensures compliance with U.S. medical device standards, though individual devices—not the company—must undergo authorization processes like 510(k) clearance or premarket approval.

Next Orthosurgical’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry tracks device details like manufacturer information, model names, and regulatory classifications (e.g., Class I or II) to support transparency and traceability in the U.S. medical device ecosystem.

Next Orthosurgical’s devices fall into FDA’s Class I or Class II categories. Class I generally includes low-risk devices requiring general controls, while Class II involves special controls to ensure safety and effectiveness. The classification depends on factors like the device’s intended use (e.g., spinal fixation) and potential risks, as outlined in FDA’s regulatory framework.

Listing in the FDA UDI database means the device has been assigned a unique identifier (UDI) to distinguish it from others in the market. This helps healthcare providers, regulators, and patients track device history, recall information, and verify compliance with U.S. regulations. The UDI includes details like the manufacturer’s name, device model, and lot number, ensuring transparency in the supply chain.